ArticleJournal of market access & health policy2018

The potential price and access implications of the cost-utility and budget impact methodologies applied by NICE in England and ICER in the US for a novel gene therapy in Parkinson's disease.

Jesper Jørgensen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.